Uncharacterized Protein, Uncharacterized (Fragment)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4ID73
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.531 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.537 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.394 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.315 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.513 |
DOC_ANK_TNKS_1 | 139 | 146 | PF00023 | 0.361 |
DOC_PP1_RVXF_1 | 133 | 139 | PF00149 | 0.333 |
DOC_PP4_MxPP_1 | 217 | 220 | PF00568 | 0.621 |
DOC_USP7_MATH_1 | 143 | 147 | PF00917 | 0.380 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.525 |
DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.501 |
LIG_14-3-3_CanoR_1 | 181 | 189 | PF00244 | 0.624 |
LIG_Actin_WH2_2 | 185 | 203 | PF00022 | 0.538 |
LIG_APCC_ABBA_1 | 19 | 24 | PF00400 | 0.500 |
LIG_BRCT_BRCA1_1 | 2 | 6 | PF00533 | 0.621 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.332 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.297 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.639 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.579 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.534 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.553 |
LIG_LIR_Apic_2 | 49 | 54 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 110 | 119 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.499 |
LIG_LIR_Nem_3 | 49 | 53 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 85 | 90 | PF02991 | 0.510 |
LIG_MLH1_MIPbox_1 | 2 | 6 | PF16413 | 0.621 |
LIG_Pex14_1 | 107 | 111 | PF04695 | 0.553 |
LIG_SH2_CRK | 87 | 91 | PF00017 | 0.482 |
LIG_SH2_CRK | 92 | 96 | PF00017 | 0.461 |
LIG_SH2_GRB2like | 50 | 53 | PF00017 | 0.481 |
LIG_SH2_PTP2 | 72 | 75 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.544 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.547 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.493 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.635 |
LIG_SUMO_SIM_par_1 | 116 | 122 | PF11976 | 0.327 |
LIG_TRAF2_1 | 220 | 223 | PF00917 | 0.635 |
LIG_TYR_ITIM | 90 | 95 | PF00017 | 0.468 |
LIG_WRC_WIRS_1 | 128 | 133 | PF05994 | 0.509 |
LIG_WRC_WIRS_1 | 148 | 153 | PF05994 | 0.426 |
MOD_GlcNHglycan | 24 | 29 | PF01048 | 0.323 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.321 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.292 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.346 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.393 |
MOD_LATS_1 | 179 | 185 | PF00433 | 0.487 |
MOD_N-GLC_1 | 114 | 119 | PF02516 | 0.329 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.235 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.363 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.525 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.527 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.492 |
MOD_Plk_1 | 114 | 120 | PF00069 | 0.330 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.325 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.274 |
MOD_SUMO_rev_2 | 204 | 208 | PF00179 | 0.627 |
MOD_SUMO_rev_2 | 76 | 81 | PF00179 | 0.588 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.519 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.502 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.489 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.502 |
TRG_ENDOCYTIC_2 | 87 | 90 | PF00928 | 0.479 |
TRG_ENDOCYTIC_2 | 92 | 95 | PF00928 | 0.464 |
TRG_ER_diArg_1 | 133 | 136 | PF00400 | 0.330 |
TRG_ER_diArg_1 | 139 | 141 | PF00400 | 0.318 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P459 | Leptomonas seymouri | 84% | 74% |
A0A0S4JIL7 | Bodo saltans | 54% | 74% |
A0A1X0P3F8 | Trypanosomatidae | 64% | 75% |
A0A3R7NG42 | Trypanosoma rangeli | 62% | 91% |
A0A3S5H831 | Leishmania donovani | 100% | 74% |
A4HPJ0 | Leishmania braziliensis | 90% | 100% |
D0A8F4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 76% |
E9ATA2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q195 | Leishmania major | 96% | 100% |
V5BIN2 | Trypanosoma cruzi | 60% | 75% |